All In Biotech

Drug Trial Radar · NCT01657448

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

Phase III, Prospective, Multicenter, Single-blind, Randomized, Superiority to Evaluate the Efficacy and Safety of Methenamine Association 250mg + Methylthioninium Chloride 20 mg Compared to Phenazopyridine 100 mg in Symptomatic Control of Dysuria

Last checked: Nov 20, 2026Latest source record: Jul 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 316 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

316

Actual

Start

Jun 27, 2016

Primary completion

Nov 21, 2016

Study completion Dec 22, 2017

Sponsor

Lead sponsor
EMSIndustry
Sponsor type
Industry
First posted
Aug 6, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of the combination of Methenamine + Methylthioninium chloride compared to phenazopyridine (comparator product) in the symptomatic relief of dysuria.

Conditions

  • Dysuria

Interventions

  • Methenamine and Methylthioninium chlorideDrug

    • Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days

  • PhenazopyridineDrug

    • Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of treatment in the symptomatic relief of dysuriaTime frame: 3 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • AFIP

    São Paulo, Brazil

  • Savmed Clinica Médica S/C Ltda.

    São Paulo, Brazil

  • Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda

    Porto Alegre, Rio Grande do Sul, Brazil

  • Marcio Antonio Pereira Clinica de Endocrinologia

    São José dos Campos, São Paulo, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.